Research Article

NT-proBNP as Early Marker of Subclinical Late Cardiotoxicity after Doxorubicin Therapy and Mediastinal Irradiation in Childhood Cancer Survivors

Figure 3

The correlation between NT-proBNP and cumulative dose of anthracycline.